A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Conditions
Pneumococcal Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Madera Family Medical Group ( Site 1004), Madera, California, United States
Acevedo Clinical Research Associates ( Site 1029), Miami, Florida, United States
University of South Florida-Department of Pediatrics ( Site 1002), Tampa, Florida, United States
Cotton O'Neil Research Center ( Site 1039), Topeka, Kansas, United States
University of Louisville, Norton Children's Research Institute ( Site 1005), Louisville, Kentucky, United States
The Pediatric Center ( Site 1025), Columbia, Maryland, United States
Saint Louis University Center for Vaccine Development ( Site 1031), St Louis, Missouri, United States
Child Health Care Associates ( Site 1035), East Syracuse, New York, United States
Tribe Clinical Research, LLC-Pediatrics ( Site 1008), Greenville, South Carolina, United States
Tribe Clinical Research - Spartanburg ( Site 1001), Spartanburg, South Carolina, United States
Epic Medical Research - Carrollton ( Site 1038), Carrollton, Texas, United States
Epic Medical Research- Garland ( Site 1017), Garland, Texas, United States
University of Texas Medical Branch ( Site 1020), League City, Texas, United States
Pediatric Research of Charlottesville, LLC ( Site 1012), Charlottesville, Virginia, United States
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC